Results 1 to 10 of about 549,420 (237)
Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines [PDF]
The 2023/2024 influenza vaccine included an updated H1N1 component designed to better match a new clade of H1N1 that had multiple mutations in antigenic epitopes of hemagglutinin.
Andrea N. Loes +15 more
doaj +2 more sources
Anti-idiotypic antibodies as molecular mimics of conserved influenza hemagglutinin epitopes. [PDF]
Abstract Broadly neutralizing antibodies (bNAbs) provide insights for developing universal influenza vaccines through their ability to neutralize diverse viral strains. However, designing antigens that reliably elicit bNAb responses remains challenging due to the difficulty in targeting conserved epitopes with a single antigen.
Itou H +7 more
europepmc +2 more sources
What Antibody Repertoires See: Structural and Immunogenetic Insights Into Influenza A Virus Hemagglutinin Recognition [PDF]
ABSTRACT Human infection with or vaccination against influenza A virus has been one of the most informative systems for understanding how human antibody repertoires recognize viral glycoproteins. Decades of antibody isolation, repertoire sequencing, lineage tracing, serology, viral antigenic evolution, and structural biology have shown that antibody ...
Bonnettaz B, Bajic G.
europepmc +2 more sources
Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells.
The viral hemagglutinins of conventional influenza A viruses (IAVs) bind to sialylated glycans on host cell surfaces for attachment and subsequent infection. In contrast, hemagglutinins of bat-derived IAVs target major histocompatibility complex class II
Okikiola M Olajide +10 more
doaj +1 more source
An aptamer is a synthetic oligonucleotide with a unique spatial structure that provides specific binding to a target. To date, several aptamers to hemagglutinin of the influenza A virus have been described, which vary in affinity and strain specificity ...
Anastasia A. Novoseltseva +9 more
doaj +1 more source
Increasing preclinical and clinical results have demonstrated that mRNA vaccines efficiently prevent infectious diseases and are safe in animal models and humans.
Wandi Zhu +7 more
doaj +1 more source
SOME INVESTIGATIONS ON RABBIT VIRAL HAEMORRHAGIC DISEASE IN UPPER EGYPT [PDF]
Rabbit hamorrhagic disease (RHD) outbreaks were observed during winter and spring, 1993 in most rabbitaries of Upper Egypt (Minia, Assiut and Sohage Provinces) with mortality rate of 26.7 up to 100% in4-16 month-old rabbits.
K.EL ZANATY
doaj +1 more source
The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype. [PDF]
Different diseases require different immune responses for efficient protection. Thus, prophylactic vaccines should prime the immune system for the particular type of response needed for protection against a given infectious agent.
Gunnveig Grødeland +4 more
doaj +1 more source
There is a crucial need for an improved H3N2 influenza virus vaccine due to low vaccine efficacy rates and increased morbidity and mortality associated with H3N2-dominated influenza seasons.
Brianna L. Bullard +6 more
doaj +1 more source
Recently, a new class of broadly neutralizing anti-influenza virus antibodies that target the stalk domain of the viral hemagglutinin was discovered. As such, induction, isolation, characterization, and quantification of these novel antibodies has become
Florian Krammer +5 more
doaj +1 more source

